Dakota Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Buy
47,326
+1,739
+4% +$333K 0.2% 109
2026
Q1
$8.36M Sell
45,587
-310
-0.7% -$57.1K 0.18% 123
2025
Q4
$8.08M Buy
45,897
+37,220
+429% +$6.08M 0.14% 126
2025
Q3
$1.22M Buy
+8,677
New +$1.17M 0.02% 326
2021
Q4
Sell
-2,290
Closed -$648K 390
2021
Q3
$648K Hold
2,290
0.07% 199
2021
Q2
$793K Hold
2,290
0.09% 172
2021
Q1
$641K Hold
2,290
0.08% 186
2020
Q4
$561K Buy
2,290
+2
+0.1% +$516 0.07% 200
2020
Q3
$649K Hold
2,288
0.1% 153
2020
Q2
$612K Hold
2,288
0.1% 151
2020
Q1
$724K Sell
2,288
-320
-12% -$97.1K 0.16% 127
2019
Q4
$774K Sell
2,608
-4
-0.2% -$1.11K 0.12% 152
2019
Q3
$608K Buy
2,612
+4
+0.2% +$931 0.1% 168
2019
Q2
$610K Hold
2,608
0.12% 156
2019
Q1
$616K Hold
2,608
0.12% 159
2018
Q4
$921K Hold
2,608
0.21% 92
2018
Q3
$921K Buy
+2,608
New +$898K 0.21% 97

Other funds holding BIIB

Dakota Wealth Management's BIIB Position: Q2 2026 in Review

Dakota Wealth Management increased its Biogen (BIIB) stake by 3.8% in Q2 2026, buying an estimated $333K and bringing the position to 47,326 shares worth $10.2M. The position accounts for 0.2% of the portfolio, ranked #109.

Dakota Wealth Management first reported a position in BIIB in Q3 2018 and has held it in 17 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Dakota Wealth Management held 47,326 shares of Biogen worth $10.2M as of Q2 2026.
  • Dakota Wealth Management bought 1,739 Biogen shares in Q2 2026, an estimated $333K.
  • Biogen made up 0.2% of Dakota Wealth Management's portfolio in Q2 2026, its #109 holding.
  • Dakota Wealth Management first reported a position in Biogen in Q3 2018 and has held it in 17 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.